Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.25 -8.62% 13.25 13.00 13.50 14.50 13.25 14.50 1,359,091 16:10:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 33

Futura Medical Share Discussion Threads

Showing 16901 to 16919 of 18750 messages
Chat Pages: Latest  678  677  676  675  674  673  672  671  670  669  668  667  Older
DateSubjectAuthorDiscuss
01/7/2019
10:20
Don't forget TPR100: TPR100 - Topical non-steroidal anti-inflammatory for the pain and inflammation associated with sprains, strains and bruises and soft tissue rheumatism Marketing authorisation application by UK commercialisation partner, Thornton & Ross (a subsidiary of STADA AG) submitted to the UK Medicines and Healthcare products Regulatory Agency (MHRA) in July 2018. Ongoing commercial discussions with several potential distribution partners for other territories. Any further licensing deals are expected to be after UK regulatory approval. TPR100 - Post year end Supporting Thornton & Ross on responses to initial MHRA feedback received in February 2019. hTTps://www.futuramedical.com/content/news/archive19/100419.asp
rrr
01/7/2019
09:57
I meant over the next day or two.
tiananmen
01/7/2019
09:35
I am particularly interested in the 56p level,where a lot of investors bought shares.
j777j
01/7/2019
09:31
44p target next
tiananmen
01/7/2019
08:26
Huge and growing marketplace. Where viagra at launch became the fastest prescription product ever launched. Med2005 works in 5 to 10 mins v up to one hour. Global Erectile Dysfunction Drugs Market Will Reach USD 7.10 Billion by 2024: Zion Market Research According to the report, global erectile dysfunction drugs market was valued at approximately USD 4.82 billion in 2017 and is expected to generate revenue of around USD 7.10 billion by end of 2024, growing at a CAGR of around 5.70% between 2018 and 2024. Inetresting to note how much larger the market is (double the size,) according to independent research is,compared to the Liberum forecast where the see 140p as level if trials are complete success. So that number could turn out to be conservative.
j777j
01/7/2019
08:04
No matter how much medication is applied at some point it will loose its effectiveness.
glavey
01/7/2019
07:42
Interestingly the share price is still 60% below 2016 levels and yet they are within 12 weeks of phase 3 results.
j777j
28/6/2019
19:19
From 7p to 35p in eight months, and now half way to being a ten bagger.
swiftnick
28/6/2019
12:40
TPR100 approval stock will hit £1+ and with positive Phase readout of MED stock will explode to £3+ and its highly likely that results will be positive .. STRONG BUYYYYYYYYYYYYYYYYYYY love it
ih_116147
28/6/2019
11:18
When you factor in the Liberum report's numbers are significantly less than Futura's 2 independent reseach forecasts indicating around $1.4 peak sales. The upside they have, could well turn out to be a low ball number. Why on earth risk taking a pill when you can apply a much faster a safer topical gel? This is disruptive technology. When the Ceo is telling us that as of yesterday they have had huge interest,makes me think he is speaking to long suffering shareholders.
j777j
28/6/2019
10:10
That's a load of potential upside from the current price.
cf456
28/6/2019
08:22
All going well, a great stock to add on the dips, charts v. Good!
ny boy
28/6/2019
07:53
Simon Thompson in the IC certainly sees the potential: "I maintain my view that Futura's share price has the potential to multiply many times over if the £62m market capitalisation company delivers the headline data that potential commercial partners are looking for." hTTps://www.investorschronicle.co.uk/comment/2019/06/20/futura-s-huge-potential-arouses-investor-interest/
cf456
28/6/2019
07:51
I think Fum have a disruptive product that could surprise in how fast it gains acceptance. Remember when Viagra launched it had around $600 million sales in year one! "At the time of its approval, Viagra had the fastest initial sales growth following its launch of any prescription product, reaching 2008 sales of close to $2 billion."
j777j
28/6/2019
06:47
htTP://www.liberum.com/videos/futura-medical
j777j
28/6/2019
06:45
Barder very bullish in latest video interview.There is "huge interest" in the Med gel.
j777j
26/6/2019
08:59
Good consolidation around the 30 mark - have to remember we have gone from 6 - 30 this year and whilst that is peanuts compared to where it will be on commercialisation I think we are good to consolidate here ready for push to 40/50 in next couple of months. I just keep adding and now very heavy here
ragnarr
26/6/2019
08:07
flurry of activity in the States recently
mikethebike4
24/6/2019
15:33
So LO now buying into Silence therapeutics.
wantage
Chat Pages: Latest  678  677  676  675  674  673  672  671  670  669  668  667  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200221 01:31:53